Pilot and Revision of a Basal-Bolus Dosing Guideline for the Management of Hyperglycemia in Noncritically Ill Adult Patients

Abstract

The use of basal-bolus insulin (BBI) regimens for the treatment of inpatient hyperglycemia has become standard of care. The purpose of this study was to develop and evaluate a newly piloted dosing guideline and utilize the results to adjust it prior to its implementation hospital-wide. This was an institutional review board approved, prospective, and multiphase study. An interdisciplinary team was developed and created a dosing guideline, which was followed by a 3-month, single-unit pilot of the guideline in noncritically ill adult patients. The resulting data were used to revise the guideline. Forty-three patients were included. There was a significant decrease in median blood glucose (BG) with use of the guideline (219 mg/dL [162-281] vs 190 mg/dL [136-246], P < .05) in patients not utilizing it. There was also a significant increase in the number of values within the target range of 70 to 180 mg/dL (30.2% vs 41.4%, P < .05). Moreover, there was comparable hypoglycemia before and after the intervention (1.6% vs 2.4%, P = .51). Based on these results, the dosing factor used for the total daily dose of insulin was increased in certain populations. Use of a BBI dosing guideline is safe and effective in decreasing BG values in noncritically ill patients at our institution.

Keywords

basal-bolus inpatient hyperglycemia insulin

Get full access to this article

View all access options for this article.

References

Umpierrez

Hellman

Korytkowski

. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.

Moghissi

Korytkowski

DiNardo

. American association of clinical endocrinologists and American diabetes association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–1131.

Inzucchi

. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(5):1903–1911.

American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2013;3 6:s11–s66.

Browning

Dumo

. Sliding-scale insulin: an antiquated approach to glycemic control in hospitalized patients. Am J Health Syst Pharm. 2004;61(15):1611–1614.

Schnipper

Ndumele

Liang

. Effects of a subcutaneous insulin protocol, clinical education, and computerized order set on the quality improvement of inpatient management of hyperglycemia: results of a clinical trial. J Hosp Med. 2009;4(1):16–27.

Umpierrez

Smiley

Zisman

. Randomized study of basal–bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181–2186.

Murphy

Vercruysse

Bertucci

. Reducing hyperglycemia hospital wide: the basal–bolus concept. Jt Comm J Qual Patient Saf. 2009;35(4):216–223.

Chen

Steinke

Karounos

. Intensive insulin protocol implementation and outcomes in the medical and surgical wards at a veterans affairs medical center. Ann Pharmacother. 2010;44(2):249–256.

10.

Maynard

Lee

Phillips

. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2009;4(1):3–15.